Search News
| 39.87 Delayed Data As of 4:02pm ET |  +0.32 / +0.81%Today’s Change | 34.52 Today|||52-Week Range 42.36 | +12.40% Year-to-Date |
| Previous close | 39.55 |
| Today’s open | 39.61 |
| Day’s range | 39.47 - 39.94 |
| Volume | 1,985,132 |
| Average volume (3 months) | 2,330,238 |
| Market cap | $98.1B |
| Earnings growth (last year) | +59.84% |
| Earnings growth (this year) | -3.99% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +3.58% |
| P/E ratio | 45.0 |
| Price/Sales | 2.25 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| BMYBristol-Myers Squibb | +0.95 | +1.56% |
| AZNAstraZeneca | +0.42 | +1.13% |
| NVONovo Nordisk | +0.50 | +1.06% |
| SNYSanofi | +0.25 | +0.57% |
| Next reporting date | October 31, 2018 |
| EPS forecast (this quarter) | $0.85 |
| Annual revenue (last year) | $38.9B |
| Annual profit (last year) | $2.0B |
| Net profit margin | 5.08% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Executive Director Emma Walmsley |
Chief Financial Officer & Executive Director Simon Paul Dingemans |
Corporate headquarters Brentford, Greater London |
